Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes

NCT07229534 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabete Mellitus

Interventions

DRUG: DA-5218
DRUG: DA-5218-C

Sponsor

Dong-A ST Co., Ltd.